Titlebook: Cell Therapy for Perinatal Brain Injury; Haruo Shintaku,Akira Oka,Makoto Nabetani Book 2018 Springer Nature Singapore Pte Ltd. 2018 Stem c

松果

蘆筍

OCTO

A New Prospective Cell Therapy for Neonatal Brain Injury,ood infusion, and recently, mesenchymal stromal cells (MSCs) have been applied. MSCs can be obtained from fetal appendages such as cord blood, umbilical cord, amnion, and placenta. In this chapter, the expected feasibility of such cell therapies for cerebral palsy is discussed.

PACK

Conclusions and further research, in CD34. cells. Proportion of CD34. cells tends to be higher in cord blood from preterm baby. The higher number of circulating CD34. cells in neonate has been found to be linked to the lower risk of prematurity-related complications. Further mechanistic studies will be required to reveal the role of circulating CD34. cells in neonate.